These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33819625)

  • 1. Drug solubilization during simulated pediatric gastro-intestinal digestion.
    Kofoed-Djursner C; Jamil A; Selen A; Müllertz A; Berthelsen R
    Eur J Pharm Sci; 2021 Jul; 162():105828. PubMed ID: 33819625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Model Simulating Gastro-Intestinal Digestion in the Pediatric Population (Neonates and Young Infants).
    Kamstrup D; Berthelsen R; Sassene PJ; Selen A; Müllertz A
    AAPS PharmSciTech; 2017 Feb; 18(2):317-329. PubMed ID: 27796909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlating in Vitro Solubilization and Supersaturation Profiles with in Vivo Exposure for Lipid Based Formulations of the CETP Inhibitor CP-532,623.
    McEvoy CL; Trevaskis NL; Feeney OM; Edwards GA; Perlman ME; Ambler CM; Porter CJH
    Mol Pharm; 2017 Dec; 14(12):4525-4538. PubMed ID: 29076741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studying furosemide solubilization using an in vitro model simulating gastrointestinal digestion and drug solubilization in neonates and young infants.
    Klitgaard M; Sassene PJ; Selen A; Müllertz A; Berthelsen R
    Eur J Pharm Sci; 2017 Nov; 109():191-199. PubMed ID: 28803922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Ferroquine on the Solubilization of Artefenomel (OZ439) during in Vitro Lipolysis in Milk and Implications for Oral Combination Therapy for Malaria.
    Salim M; Khan J; Ramirez G; Murshed M; Clulow AJ; Hawley A; Ramachandruni H; Beilles S; Boyd BJ
    Mol Pharm; 2019 Apr; 16(4):1658-1668. PubMed ID: 30830789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-Frequency Raman Scattering Spectroscopy as an Accessible Approach to Understand Drug Solubilization in Milk-Based Formulations during Digestion.
    Salim M; Fraser-Miller SJ; Be Rziņš KR; Sutton JJ; Ramirez G; Clulow AJ; Hawley A; Beilles S; Gordon KC; Boyd BJ
    Mol Pharm; 2020 Mar; 17(3):885-899. PubMed ID: 32011151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid Compositions in Infant Formulas Affect the Solubilization of Antimalarial Drugs Artefenomel (OZ439) and Ferroquine during Digestion.
    Salim M; Ramirez G; Peng KY; Clulow AJ; Hawley A; Ramachandruni H; Beilles S; Boyd BJ
    Mol Pharm; 2020 Jul; 17(7):2749-2759. PubMed ID: 32574056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations.
    Kaukonen AM; Boyd BJ; Porter CJ; Charman WN
    Pharm Res; 2004 Feb; 21(2):245-53. PubMed ID: 15032305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids.
    Kaukonen AM; Boyd BJ; Charman WN; Porter CJ
    Pharm Res; 2004 Feb; 21(2):254-60. PubMed ID: 15032306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding a Gastric Step to the Intestinal
    Klitgaard M; Beilles S; Sassene PJ; Berthelsen R; Müllertz A
    Mol Pharm; 2020 Sep; 17(9):3214-3222. PubMed ID: 32662647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of neonatal and infant enterostomy fluids - part II: Drug solubility.
    de Waal T; Brouwers J; Rayyan M; Stillhart C; Vinarova L; Vinarov Z; Augustijns P
    Int J Pharm; 2023 Jul; 642():123141. PubMed ID: 37321462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Models of the Gastrointestinal Environment. 2. Phase Behavior and Drug Solubilization Capacity of a Type I Lipid-Based Drug Formulation after Digestion.
    Birru WA; Warren DB; Han S; Benameur H; Porter CJ; Pouton CW; Chalmers DK
    Mol Pharm; 2017 Mar; 14(3):580-592. PubMed ID: 27936778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach.
    Kossena GA; Charman WN; Boyd BJ; Dunstan DE; Porter CJ
    J Pharm Sci; 2004 Feb; 93(2):332-48. PubMed ID: 14705191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility to lipase-mediated digestion reduces the oral bioavailability of danazol after administration as a medium-chain lipid-based microemulsion formulation.
    Porter CJ; Kaukonen AM; Boyd BJ; Edwards GA; Charman WN
    Pharm Res; 2004 Aug; 21(8):1405-12. PubMed ID: 15359575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Lipid Digestion and Drug Permeation/Re-Dissolution on Absorption of Orally Administered Ritonavir as Different Lipid-Based Formulations.
    Tanaka Y; Doi H; Katano T; Kasaoka S
    Eur J Pharm Sci; 2021 Feb; 157():105604. PubMed ID: 33098990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of Artefenomel (OZ439) with Milk during Digestion: Insights into Digestion-Driven Solubilization and Polymorphic Transformations.
    Salim M; Khan J; Ramirez G; Clulow AJ; Hawley A; Ramachandruni H; Boyd BJ
    Mol Pharm; 2018 Aug; 15(8):3535-3544. PubMed ID: 29932660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties: Case Study-Hypromellose (HPMC).
    Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
    AAPS J; 2020 Feb; 22(2):49. PubMed ID: 32072317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid determination of drug solubilization versus supersaturation in natural and digested lipids.
    Gautschi N; Bergström CA; Kuentz M
    Int J Pharm; 2016 Nov; 513(1-2):164-174. PubMed ID: 27609663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.